ETR vs GRCE · P/E 28, rev $12.95B vs $35.0M cap
Entergy Corporation (ETR) versus Grace Therapeutics, Inc. (GRCE) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
GRCE does not have a complete income-statement cache yet.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. GRCE currently screens at market cap $35.0M.
Not investment advice. Open the ETR and GRCE stock pages for the full models.
Not investment advice.